Benzoyl peroxide - Maruho

Drug Profile

Benzoyl peroxide - Maruho

Alternative Names: Bepio; M6050; M605101

Latest Information Update: 28 Feb 2017

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Maruho
  • Class Anti-infectives; Antiacnes; Benzoic acids; Oxidants; Small molecules
  • Mechanism of Action Keratinocyte inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Acne vulgaris

Most Recent Events

  • 16 Feb 2017 Maruho plans a open label, randomised trial for Acne vulgaris (Combination therapy, In adolescents, In adults) in Japan (UMIN000024874)
  • 26 Dec 2014 Launched for Acne vulgaris in Japan (Topical) after December 2014
  • 26 Dec 2014 Registered for Acne vulgaris in Japan (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top